Nov.
Archive for November, 2009
Celgene Cancer Pill to Triple Sales on Threat to J&J (Update2) (Bloomberg)
Published November 30th, 2009 in Osteosarcoma News. 0 CommentsA cheaper way to scan for cancer (CNN Money)
Published November 30th, 2009 in Osteosarcoma News. 0 CommentsGreg Colip had a comfortable life as a Houston attorney specializing in the oil-and-gas industry.
A cheaper way to scan for cancer (Fortune Small Business via Yahoo! Finance)
Published November 30th, 2009 in Osteosarcoma News. 0 CommentsGreg Colip had a comfortable life as a Houston attorney specializing in the oil-and-gas industry. He never thought he’d become an expert in cancer screening. That changed when a friend arranged a quick chat with Jerry Bryant, a local scientist, in a hotel lobby.
Celgene Cancer Pill to Triple Sales on Threat to J&J (Update1) (Bloomberg)
Published November 30th, 2009 in Osteosarcoma News. 0 CommentsNov. 30 (Bloomberg) — Celgene Corp. can more than triple sales for its best-selling cancer pill Revlimid on new data that may convince doctors to choose the drug as a first option over Johnson & Johnson’s intravenous medicine, Velcade.
Celgene Cancer Pill to Triple Sales on Data Threatening J&J (Bloomberg)
Published November 30th, 2009 in Osteosarcoma News. 0 CommentsNov.
Recent Comments